The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Clinical Phenotype and Mutant TRα1
Open accessAbstract
Generic Atorvastatin and Health Care CostsTo the Editor: In their Perspective article on generic atorvastatin and health care costs, Jackevicius et al. (Jan.19 issue) 1 refer to agreements that we at Pfizer have reached with health plans and pharmacy benefit managers to ensure that patients can continue to have access to Lipitor in the 180-day period after the loss of market exclusivity.They ask "whether these agreements will discourage generics manufacturers from competing in the atorvastatin market."We believe our programs (the Lipitor for You program and Lipitor contracting strategies with payers and retail pharmacies) enhance competition by affording both patients and payers access to branded Lipitor at a cost that is at or lower than the cost of a generic during the 180-day period following the loss of market exclusivity.In addition to Lipitor, generic alternatives from Ranbaxy and Watson are also available.After the 180day period, we expect that multiple additional generics will enter the market and that the cost of generic products will decline appreciably.We appreciate the focus on ways to safely and effectively cut costs in the U.S. health care system.We believe we are doing just that by introducing greater competition to the marketplace earlier than would occur without our programs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Mutation in the Thyroid Hormone Receptor Alpha Gene
Bochukova, E., Schoenmakers, N., Agostini, M., Schoenmakers, E., Rajanayagam, O., Keogh, J. M., Henning, E., Reinemund, J., Gevers, E., Sarri, M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110296 · Cited by 379
Cited by
Thyroid Hormone Regulation of Metabolism
Mullur, R., Liu, Y.-Y., & Brent, G. A. (2014) · Physiological Reviews · doi:10.1152/physrev.00030.2013 · Cited by 2,421
Jonklaas, J., Bianco, A. C., Bauer, A. J., Burman, K. D., Cappola, A. R., Celi, F. S., Cooper, D. S., Kim, B. W., Peeters, R. P., Rosenthal, M. S., et al. (2014) · Thyroid® · doi:10.1089/thy.2014.0028 · Cited by 1,928
Self-citationMechanisms of thyroid hormone action
Brent, G. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60047 · Cited by 1,244
Qato, D. M., Wilder, J., Schumm, L. P., Gillet, V., & Alexander, G. C. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.8581 · Cited by 658
Whole-genome sequencing of quartet families with autism spectrum disorder
Yuen, R. K. C., Thiruvahindrapuram, B., Merico, D., Walker, S., Tammimies, K., Hoang, N., Chrysler, C., Nalpathamkalam, T., Pellecchia, G., Liu, Y., et al. (2015) · Nature Medicine · doi:10.1038/nm.3792 · Cited by 514
Metadata
- Authors
- van Mullem, A., van Heerebeek, R., Chrysis, D., Visser, E., Medici, M., Andrikoula, M., Tsatsoulis, A., Peeters, R., & Visser, T. J.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2012-04-12
- Volume
- 366
- Issue
- 15
- Pages
- 1451-1453
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1978781687
- Cited by
- 223
- References
- 1
- FWCI
- 67.42
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical Phenotype and Mutant TRα1. https://app.cochat.ai/papers/10.1056/nejmc1113940
- The paper
- van Mullem, A., van Heerebeek, R., Chrysis, D., Visser, E., Medici, M., Andrikoula, M., Tsatsoulis, A., Peeters, R., & Visser, T. J. (2012). Clinical Phenotype and Mutant TRα1. New England Journal of Medicine. https://doi.org/10.1056/nejmc1113940
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.